CARBOGEN AMCIS Sitemap
- Knowledge Centre & Open Positions
- Articles
- 5 things to consider when choosing your drug product CDMO
- Antibody Drug Conjugates and Bioconjugation made in Bubendorf
- CARBOGEN AMCIS 2023 Spring Science Day Event
- CARBOGEN AMCIS Apprenticeship Diaries - Eveline
- CARBOGEN AMCIS Apprenticeship Diaries - Philip
- CARBOGEN AMCIS receives CDMO Leadership Awards 2024
- CARBOGEN AMCIS Veenendaal - Solvent-free in 2030?
- CARBOGEN AMCIS's Journey Featured on PharmaSource Podcast
- CDMO Europe: how to choose yours?
- Chromatography Services offered in Switzerland
- Criticality-based Process Data Evaluation: Our tool to navigate process data
- Custom Development and Manufacture of Fine Chemicals
- Data Integrity: A Key Topic for CARBOGEN AMCIS as a leading API Supplier
- Driving Change: The Sustainable Trajectory of CARBOGEN AMCIS Manchester
- Formulation and Development of Injectable Drug Product at CARBOGEN AMCIS
- Highly Potent Active Pharmaceutical Ingredients at CARBOGEN AMCIS
- Interview Chemtogether 2017 Dr. Jonas Bürgler
- Interview Chemtogether 2021 Dr. Volker Wolfart
- Interview Chemtogether 2022 Dr. Luca Mannocci
- Interview For Chemtogether 2019 Dr. Volker Wolfart
- Interview with Dr. Gavin Schmid, Head of Environment, Safety & Health
- Interview with Emad El Sayed, Ph.D.
- Interview with Jeroen de Jong, Manager Risk & Compliance
- Investigating Human Error in Pharmaceutical Manufacturing
- Large Scale Metal Scavenging and Associated Decolorization at CARBOGEN AMCIS Shanghai
- Our approach in Drug Product Development & Manufacture
- Process Development in China at CARBOGEN AMCIS + Case Study
- Pushing Boundaries in API Synthesis: Our Journey to Elevate Clazosentan Production Featured in OPR&D Publication
- Q&A with Cor Veldhuizen, CARBOGEN AMCIS’ Global Head of Vitamin D analogues
- Saint-Beauzire: opening ceremony of our new site in France dedicated to Drug Products
- Simulated Moving Bed chromatography at CARBOGEN AMCIS AG
- The Evolution of Flow Chemistry
- Brochures
- Careers
- Bring your future to life at CARBOGEN AMCIS: we're hiring!
- CARBOGEN AMCIS Apprenticeship Diaries - Eveline
- CARBOGEN AMCIS Apprenticeship Diaries - Philip
- Criticality-based Process Data Evaluation: Our tool to navigate process data
- Interview Chemtogether 2017 Dr. Jonas Bürgler
- Interview Chemtogether 2021 Dr. Volker Wolfart
- Interview For Chemtogether 2019 Dr. Volker Wolfart
- Interview with Dr. Gavin Schmid, Head of Environment, Safety & Health
- Interview with Emad El Sayed, Ph.D.
- Q&A with Cor Veldhuizen, CARBOGEN AMCIS’ Global Head of Vitamin D analogues
- The Evolution of Flow Chemistry
- We're hiring in Production | Wir suchen Mitarbeitende in der Produktion
- Case Studies
- Chemical Engineering at CARBOGEN AMCIS - Part 1
- Development & Aseptic Production of Drug Products
- Development and Scale-up of a Miyaura Borylation Process
- Discovery & Development of a New ADC
- Large Scale Metal Scavenging and Associated Decolorization at CARBOGEN AMCIS Shanghai
- Mastering the Supply Chain
- Simulated Moving Bed chromatography at CARBOGEN AMCIS AG
- Technology Transfer
- Thermal Overman Rearrangement of a Glucal Derivative
- Expansion News
- "140 neue Jobs am Standort Hunzenschwil"
- "CARBOGEN AMCIS accélère dans le domaine du médicament injectable"
- "CARBOGEN AMCIS développe des médicaments injectables"
- "CARBOGEN AMCIS lance une nouvelle unité de fabrication de produits injectables"
- "CARBOGEN AMCIS to expand pharmaceutical services in Europe"
- "Der lange Weg zur Chemiefabrik in Hunzenschwil"
- "Dreistellige Millioneninvestition"
- "Les travaux de la nouvelle usine pharmaceutique CARBOGEN AMCIS"
- CARBOGEN AMCIS expands capacity for parenteral drug manufacturing
- CARBOGEN AMCIS Virtual DCAT Member Company Announcement Forum - Mark Griffiths
- Ground breaking Riom 2, France
- New Drug Products Facility
- Radio SRF1 - Regionaljournal Aargau Solothurn
- Saint-Beauzire: opening ceremony of our new site in France dedicated to Drug Products
- Teaser Riom 2 - Episode 2: The work is continuing
- Teaser Riom 2 project - Work has begun
- Open Positions
- (Senior) ESH Officer (m/w/d) 80-100%
- Analytical Development Chemist (NMR Specialist)
- Animateur production H/F CDI
- Assistant laboratoire CDI H/F
- Chemie- und Pharmatechnologe / Chemikant (m/w/d)
- Directeur Qualité et pharmacien responsable H/F CDI
- Gestionnaire de base de données H/F – CDI
- GPO Bubendorf
- Head of Project Management Development Programs (m/w/d)
- HR Business Partner (m/w/d)
- Ingénieur Process confirmé H/F CDI
- Labor Projektverantwortlicher in der QC (Expert QC&A) (m/w/d)
- Lehrstelle Laborant/in EFZ (m/w/d) Fachrichtung Chemie
- Manager PR&D (m/w/d)
- Mechanic Maintenance (m/w/d)
- Procesoperator (in opleiding / Young Professional)
- Process Chemist PR&D (m/w/d)
- Production Supporter Logistic (m/w/d)
- Production Technician
- Production Technician
- Quality Control (QC) Chemist
- Responsable production H/F CDI
- Senior Manager Corporate Regulatory Affairs & CMC (RAC)
- Senior Mechanic Maintenance (m/w/d)
- Senior Mechanic Maintenance (m/w/d)
- Technical Production Supporter 50-100% (m/w/d)
- Technicien de maintenance H/F CDI
- Senior Lab Technician QC&A (m/w/d)
- Business Analyst / Internal Consultant Material Services (SAP) (m/w/d)
- Lab Technician QC&A (m/w) im Bereich Stabilitätsstudien und Referenzstandards
- Production Technician 100% (m/w/d)
- Senior Accountant 80-100% (m/w/d)
- Press Mentions
- "140 neue Jobs am Standort Hunzenschwil"
- "CARBOGEN AMCIS accélère dans le domaine du médicament injectable"
- "CARBOGEN AMCIS développe des médicaments injectables"
- "CARBOGEN AMCIS lance une nouvelle unité de fabrication de produits injectables"
- "CARBOGEN AMCIS to expand pharmaceutical services in Europe"
- "Der lange Weg zur Chemiefabrik in Hunzenschwil"
- "Dreistellige Millioneninvestition"
- "Grosse Investitionen im Kampf gegen Krebs"
- "How the drug services industry found itself prepared for a pandemic"
- "Les travaux de la nouvelle usine pharmaceutique CARBOGEN AMCIS"
- 5 Minutes Interview with Dishman CARBOGEN AMCIS
- CARBOGEN AMCIS's Journey Featured on PharmaSource Podcast
- Chemical & Engineering News - "Pharmaceutical Outsourcing"
- Interview with Mark Griffiths – Group CEO, Dishman Group
- Making a step change
- Panel Discussion on Flow Chemistry
- Panel Discussion on Flow Chemistry
- Panel discussion on HPAPIs - Chemistry Today September/October 2022
- Pharma's Almanac
- Pushing Boundaries in API Synthesis: Our Journey to Elevate Clazosentan Production Featured in OPR&D Publication
- Radio SRF1 - Regionaljournal Aargau Solothurn
- Regierungsrat Basel-Landschaft besucht die CARBOGEN AMCIS AG
- Regierungsrat Dieter Egli visits CARBOGEN AMCIS in Hunzenschwil
- Speciality Chemicals Magazine: CARBOGEN AMCIS featured on High Potency APIs
- Scientific Publications
- 2-(Diethylamino)ethanethiol
- A bridgehead amine with planar nitrogens
- ACS OMEGA Publication: CARBOGEN AMCIS Researchers Contribute to Protein Conjugation Advancements
- Cage-like molecules with triple bonds
- Chiroptical Properties of some Monoazapentahelicenes
- Example of a Stereoselective Synthesis in Industrial API Manufacture
- HMG-CoA Reductase Inhibitor
- Identification of a 1,2,4,5-Tetraoxane Antimalarial Drug-Development Candidate
- Large scale preparation of 3-Methyl-4H-[ 1, 2, 4]oxadiazol-5-one
- Mastering the Supply Chain
- Process Development and Multikilogram Syntheses of XL228
- Process Optimization for GSK369796 (N-tert-Butyl Isoquine)
- Process scale-up of cis-N-Benzyl-3-methylamino-4-methylpiperidine
- Pushing Boundaries in API Synthesis: Our Journey to Elevate Clazosentan Production Featured in OPR&D Publication
- Reaction of N,N'-bridged 1,10-diazacyclooctadeca-5,14-diynes with [ CpCo(cod)]
- Reactions of 1,8‐Diheterocyclotetradeca‐4,11‐diynes
- Safety Assessment for the Scale-up of an Oxime Reduction
- Scale-up of a high temperature Claisen synthesis
- Syntheses and properties of N,N′-bridged-1,10-diazabicyclooctadeca-5,14-diynes
- Synthesis and Structural Properties of Bridged 1,8‐Diazacyclotetradeca‐4,11‐diynes
- Synthesis of (S)-1-Boc-2,5-dihydro-1H-pyrrole-2- carboxylic Acid
- Synthesis of 2-Amino-8-hydroxyquinoline
- Videos
- Advancing ADC and Drug Product Solutions: CARBOGEN AMCIS Expertise
- Bring your future to life at CARBOGEN AMCIS: we're hiring!
- CARBOGEN AMCIS Drug Products New Site: Opening Ceremony video
- CARBOGEN AMCIS Passion For Science
- CARBOGEN AMCIS Virtual DCAT Member Company Announcement Forum - Mark Griffiths
- Customer Journey at CARBOGEN AMCIS
- Interview Nobel Laureate Prof. Lehn
- Interview Pascal Villemagne, VP Sales and Marketing at CARBOGEN AMCIS, for "Paroles d'experts"
- MedinCell X CARBOGEN AMCIS: A Partnership for Global Health
- New Drug Products Facility
- Our locations and services in video
- Teaser Riom 2 - Episode 2: The work is continuing
- Teaser Riom 2 project - Work has begun
- We're hiring in Production | Wir suchen Mitarbeitende in der Produktion
- Articles
- News & Events
- News
- CARBOGEN AMCIS Announces Two Successful FDA Inspections at Its Manufacturing Sites in Neuland and Aarau, Switzerland
- CARBOGEN AMCIS announces successful ANVISA audit of its facility in China
- CARBOGEN AMCIS Manchester wins prestigious Chemical Industry Award for world-class manufacturing performance
- CARBOGEN AMCIS announces successful FDA and Swissmedic inspections of its facilities in Switzerland
- CARBOGEN AMCIS opens new state-of-the-art facility dedicated to sterile liquid drug product manufacturing in France
- CARBOGEN AMCIS announces successful Swissmedic inspection at Vionnaz, Switzerland
- CARBOGEN AMCIS appointed new Vice President of Business Development, Sales & Marketing
- Pascal Villemagne appointed new CARBOGEN AMCIS Chief Executive Officer (CEO)
- Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on Clinical Research Study that reveals positive response in vitamin D deficiency/insufficiency in patients with COVID-19
- NH TherAguix announces the release of a new clinical batch for its drug AGuIX, manufactured by CARBOGEN AMCIS
- CARBOGEN AMCIS announces successful FDA inspection of its facility in Aarau, Switzerland
- CARBOGEN AMCIS announces a co-investment agreement of more than CHF 4 million with a long-standing Europe-based client
- Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on study that uncovers treatment for vitamin D deficiency (2)
- CARBOGEN AMCIS announces a co-investment agreement of more than CHF 15 million with a key client to expand Swiss site
- CARBOGEN AMCIS acquires new property at Bubendorf site
- CARBOGEN AMCIS announces major investments of more than CHF 100 million in Switzerland and France
- COVID-19
- Successful FDA Inspection at Neuland, Switzerland
- ISO22716 Cosmetics GMP standard accreditation
- Dishman Carbogen Amcis Opens Office in Kyoto, Japan
- CARBOGEN AMCIS Announces a Successful Swissmedic Inspection of its Site in Vionnaz, Switzerland
- CARBOGEN AMCIS AG Makes Capital Investments in ADC
- CARBOGEN AMCIS AG Continues to Invest in Expanding High Potency Capabilities
- CARBOGEN AMCIS Expands Operations in Switzerland
- CARBOGEN AMCIS CEO Mark Griffiths Appointed to Dishman Board of Directors
- CARBOGEN AMCIS Passes Successful Inspection by Swissmedic
- CARBOGEN AMCIS Expands Operations in Bubendorf
- CARBOGEN AMCIS Sites at Aarau and Neuland in Switzerland Successfully Pass FDA Inspection
- Dishman Celebrates a Decade of Success Since Acquisition of CARBOGEN AMCIS
- CARBOGEN AMCIS Sites at Bubendorf, Aarau and Neuland in Switzerland Successfully Pass Swissmedic Inspection
- CARBOGEN AMCIS Announces a Successful FDA Inspection of its Headquarters Site in Bubendorf, Switzerland
- News